Life ScienceCompany
Ligand Pharmaceuticals M&A Summary
Ligand Pharmaceuticals has acquired 16 companies, including 8 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 1 asset.
Ligand Pharmaceuticals’ largest acquisition to date was in 2020, when it acquired Pfenex for $438M. It’s largest disclosed sale occurred in 2020, when it sold Vernalis to HitGen for $25M. Ligand Pharmaceuticals has acquired in 6 different US states, and 3 countries. The Company’s most targeted sectors include life science (94%) and medical products (7%).
Ligand Pharmaceuticals Business Overview
Where is Ligand Pharmaceuticals headquartered?
Ligand Pharmaceuticals is headquartered in Jupiter, California.
What is Ligand Pharmaceuticals’ revenue?
Ligand Pharmaceuticals disclosed revenue of 131M USD for 2023 and 196M USD for 2022.
How many employees does Ligand Pharmaceuticals have?
Ligand Pharmaceuticals has 58 employees.
What sector is Ligand Pharmaceuticals in?
Ligand Pharmaceuticals is a life science company.
When was Ligand Pharmaceuticals founded?
Ligand Pharmaceuticals was founded in 1987.
M&A Summary
-
M&A Total Activity17
- M&A Buy Activity16
- M&A Sell Activity1
- Total Sectors Invested 2
- Total Countries Invested 3
- M&A Buy/Sell Connections 4
- M&A Advisors 6
Unlimited Searches
